PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
15857610-0	2005	Differential inhibition of cellular glutathione reductase activity by isocyanates generated from the antitumor prodrugs Cloretazine and BCNU.	laromustine	120-131	glutathione-disulfide reductase	Homo sapiens	36-57	
15857610-8	2005	The superior antineoplastic potential of Cloretazine compared to BCNU in animal models could be attributed in part to the contribution of the methyl isocyanate, which is synergistic with the co-generated cytotoxic alkylating species, while at the same time unable to significantly inhibit cellular GR.	laromustine	41-52	glutathione-disulfide reductase	Homo sapiens	298-300